---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-098429"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2025-07-24T23:59:59+00:00"
generated_at: "2026-05-18T02:23:48.693645+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Aptevo shareholders approve reverse stock split and Yorkville equity issuance

## Summary
- Elected directors Marvin L. White (443,945 for) and John E. Niederhuber (444,661 for) to board.
- Approved reverse stock split at ratio 1:6 to 1:20, board to set timing and exact ratio.
- Approved issuance of >19.99% of outstanding shares under SEPA with YA II PN, Ltd. (Yorkville).
- Approved Third Amended and Restated 2018 Stock Incentive Plan and non-binding advisory say-on-pay.
- Ratified Baker Tilly as independent auditor for fiscal 2025.

## SEC filing metadata
- accession: 0000950170-25-098429
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2025-07-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017025098429/0000950170-25-098429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017025098429/apvo-20250724.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-098429
- JSON: https://secwatch.observer/filing/0000950170-25-098429.json
- Plain text: https://secwatch.observer/filing/0000950170-25-098429.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.